Insider Transactions Reported by 14 Insiders of TENAX THERAPEUTICS, INC.

Symbol
TENX on Nasdaq
Location
Chapel Hill, NC

Insiders trading volume in the past year

TENAX THERAPEUTICS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Christopher Thomas Giordano CEO, Director $4,073,445 +$20,000 +0.49% 09 Jan 2026
Stuart Rich Chief Medical Officer, Director $2,363,886 +$96,414 +4.3% 09 Jan 2026
Michael H. Davidson Director $948,429 09 Jan 2026
PROEHL GERALD T Director $719,829 09 Jan 2026
Declan Doogan Director $290,466 09 Jan 2026
June Sherie Almenoff Director $287,937 +$14,945 +5.5% 09 Jan 2026
Robyn Hunter Director $270,000 09 Jan 2026
THOMAS MCGAULEY Interim CFO $72,000 +$58,164 +420% 30 Jan 2026
LAWRENCE R. HOFFMAN Interim CFO 11 Jan 2024
Anthony A. DiTonno CEO, Director 06 Jul 2021
Eliot M. Lurier Interim CFO 29 Oct 2021
James P. Mitchum Director 10 Jun 2021
ARMISTICE CAPITAL, LLC Director 18 May 2022
Dellora Investments LP no longer 10% owner 05 Mar 2025

Recent Insider Transactions by Companies or Individuals for TENAX THERAPEUTICS, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.